Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin

Title
Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin
Authors
Keywords
Apixaban, Cancer, Thrombin generation, Anticoagulant, NOAC, Low molecular weight heparin, Fondaparinux
Journal
THROMBOSIS RESEARCH
Volume 136, Issue 6, Pages 1273-1279
Publisher
Elsevier BV
Online
2015-09-03
DOI
10.1016/j.thromres.2015.08.009

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started